iCad (NSDQ:ICAD) shook up its board of directors after a member tendered his resignation, naming a new chairman and re-jiggering the composition of its oversight committees. Andy Sassine, a longtime shareholder who owns a 7.5% stake in the cancer detection company, joined the board in 2015. In his Sept. 26 resignation letter, Sassine said he […]
iCad Inc.
7 medtech stories we missed this week: March 2, 2018
From InspireMD’s new distribution deals to Kelynium’s distribution deal with a mystery partner, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. InspireMD inks distribution deals in Greece, Caribbean InspireMD announced in a March 1 press release that it has signed exclusive distribution agreements with T-Vascular IKE Medical Supplies […]
iCad wins Chinese approval for Xoft Axxent balloon applicators
iCad (NSDQ:ICAD) said today its Xoft Axxent balloon applicators have been cleared by the China Food & Drug Administration for treating early-stage breast cancer. The Nashua, N.H.-based company’s Xoft Axxent balloon applicators are part of its Xoft Axxent electronic brachytherapy system designed to perform intraoperative radiation therapy in early-stage breast cancer patients who meet specific selection […]
iCad closes sale of VersaVue, DynaCAD to Philips Invivo
iCad (NSDQ:ICAD) said today it closed its sale of its VersaVue software and DynaCAD breast and prostate imaging devices to Royal Philips‘ (NYSE:PHG) Invivo unit for $3.2 million. Nashua, N.H.-based iCad said the deal includes a holdback reserve of $350,000. With the close of the deal, Philips Invivo will have all right, title and interest to […]
iCad deals VersaVue software, DynaCAD to Philips InVivo unit for $3.2m
iCad (NSDQ:ICAD) said yesterday that it agreed to deal its VersaVue software and DynaCAD breast and prostate imaging devices to Royal Philips‘ (NYSE:PHG) InVivo unit for $3.2 million. Nashua, N.H.-based iCad said the Dec. 16 deal includes a holdback reserve of $350,000. The deal is expected to close by Jan. 31, 2017; if it doesn’t close by […]
Misonix CEO steps down | Personnel Moves October 4, 2016
Misonix CEO steps down Misonix (NSDQ:MSON) CEO Michael McManus, Jr. stepped down in early September, also leaving his post as director and chairman of the board of directors. Stavros Vizirgianakis, a member of the board of directors, is serving as the interim CEO while negotiating for a full-time position in the corner office. Vizirgiankis, who owned […]
iCad closes VuComp cancer portfolio buyout
iCad (NSDQ:ICAD) said today it completed its acquisition of VuComp’s cancer detection portfolio, including the M-Vu computer aided detection technology platform. The buy includes a library of related clinical data as well as VuComp’s key personnel and existing customer base. iCad had previously acquired VuComp’s M-Vu breast density software product in April last year. “This […]
Ex-Insulet CEO DeSisto is new chief exec at MannKind | Personnel Moves
MannKind Corporation said last week it picked up ex-Insulet (NSDQ:PODD) CEO Duane DeSisto as its new prez and CEO, effective January 5, 2016. DeSisto will replace interim CEO Alfred Mann, who has held the spot since November. DeSisto will also join the company’s board of directors, according to a press release from the Valencia, Calif.-based company. […]
RSNA Roundup: Researchers refine X-ray tech with Kinect gaming sensor
Microsoft‘s (NSDQ:MSFT) Kinect, originally developed as a motion sensor for its Xbox gaming systems, is helping researchers refine X-ray imaging through analysis of body part thickness, motion and positioning, researchers said today, and with the use of the best wireless router
Study: Computer-aided mammograms fail to improve detection, raise costs
Computer-aided breast cancer screening technology designed to boost accuracy have failed to increase detection, according to a new study published yesterday in the journal JAMA Internal Medicine. The technology, from companies like Hologic (NSDQ:HOLX) and iCad (NSDQ:ICAD) failed to improve detection of cancerous tumors, according to the report. “We found no evidence that CAD applied to digital […]
Ex-Medtronic strategy veep Oesterle joins VC shop New Enterprise Associates | Personnel Moves
Venture capital firm New Enterprise Associates said today it picked up ex-Medtronic (NYSE:MDT) executive veep Dr. Stephen Oesterle as a venture partner for the firm. Prior to being an executive veep for the medical giant, Oesterle served as senior veep of medicine and technology, and served as a member of the executive committee for 14 years, […]
